Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-24 @ 7:23 PM
NCT ID:
NCT02687503
Eligibility Criteria:
Inclusion Criteria
* Healthy children greater than 12 months-36 months of age
* English speaking parent
* Child has not received a live vaccine such as MMR or Varicella in the past 2 weeks
Exclusion Criteria
* Asthma/allergic rhinitis
* Premature birth (\< 36 weeks gestation)
* Known to be lactose intolerant
* Immunodeficiency or any underlying problem requiring the use of steroids or other immunosuppressive agents
* Use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen in the last 2 weeks
* Currently taking probiotics, have received probiotics in the previous two weeks or are unwilling to refrain from the use of non-study probiotics during the next 30 days
* Any antibiotic treatment in the last 2 weeks
* Conditions which might interfere with dispersion of the probiotic after oral administration such as short gut or anomalies of the digestive tract
* Concurrently participating in another clinical study, in which the child has been or will be exposed to an investigational or a non-investigational product (pharmaceutical product or device).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
36 Months
Study:
NCT02687503
Study Brief:
Protocol Section:
NCT02687503